Emmanuel Bouchaert
Overview
Explore the profile of Emmanuel Bouchaert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
812
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raffo-Romero A, Aboulouard S, Bouchaert E, Rybicka A, Tierny D, Hajjaji N, et al.
BMC Biol
. 2023 Feb;
21(1):23.
PMID: 36737789
Background: Cancer heterogeneity is a main obstacle for the development of effective therapies, as its replication in in vitro preclinical models is challenging. Around 96% of developed drugs are estimated...
2.
Goy E, Tomezak M, Facchin C, Martin N, Bouchaert E, Benoit J, et al.
Elife
. 2022 Mar;
11.
PMID: 35302491
A rare but severe complication of curative-intent radiation therapy is the induction of second primary cancers. These cancers preferentially develop not inside the planning target volume (PTV) but around, over...
3.
Ogrinc N, Caux P, Robin Y, Bouchaert E, Fatou B, Ziskind M, et al.
Clin Chem
. 2021 Sep;
67(11):1513-1523.
PMID: 34586394
Background: Formalin-fixed paraffin-embedded (FFPE) tissue has been the gold standard for routine pathology for general and cancer postoperative diagnostics. Despite robust histopathology, immunohistochemistry, and molecular methods, accurate diagnosis remains difficult...
4.
Boye P, Floch F, Serres F, Segaoula Z, Hordeaux J, Pascal Q, et al.
Oncotarget
. 2020 Mar;
11(7):671-686.
PMID: 32133044
F14512 is an epipodophyllotoxin derivative from etoposide, combined with a spermine moiety introduced as a cell delivery vector. The objective of this study was to compare the safety and antitumor...
5.
Tian L, Truong M, Lagadec C, Adriaenssens E, Bouchaert E, Bauderlique-Le Roy H, et al.
Stem Cell Reports
. 2019 Jun;
13(1):10-20.
PMID: 31204299
During normal mammary gland development, s-SHIP promoter expression marks a distinct type of mammary stem cells, at two different stages, puberty and early mid-pregnancy. To determine whether s-SHIP is a...
6.
Paumelle R, Haas J, Hennuyer N, Bauge E, Deleye Y, Mesotten D, et al.
J Hepatol
. 2019 Jan;
70(5):963-973.
PMID: 30677458
Background & Aims: Although the role of inflammation to combat infection is known, the contribution of metabolic changes in response to sepsis is poorly understood. Sepsis induces the release of...
7.
Segaoula Z, Primot A, Lepretre F, Hedan B, Bouchaert E, Minier K, et al.
BMC Cancer
. 2018 Dec;
18(1):1219.
PMID: 30514258
Background: Metastatic melanoma is one of the most aggressive forms of cancer in humans. Among its types, mucosal melanomas represent one of the most highly metastatic and aggressive forms, with...
8.
Wouters K, Deleye Y, Hannou S, Vanhoutte J, Marechal X, Coisne A, et al.
Diab Vasc Dis Res
. 2017 Sep;
14(6):516-524.
PMID: 28868898
The genomic CDKN2A/B locus, encoding p16 among others, is linked to an increased risk for cardiovascular disease and type 2 diabetes. Obesity is a risk factor for both cardiovascular disease...
9.
Boye P, Serres F, Marescaux L, Hordeaux J, Bouchaert E, Gomes B, et al.
PLoS One
. 2017 May;
12(5):e0177486.
PMID: 28505195
Comparative oncology has shown that naturally occurring canine cancers are of valuable and translatable interest for the understanding of human cancer biology and the characterization of new therapies. This work...
10.
Everaere L, Ait-Yahia S, Molendi-Coste O, Vorng H, Quemener S, LeVu P, et al.
J Allergy Clin Immunol
. 2016 May;
138(5):1309-1318.e11.
PMID: 27177781
Background: Epidemiologic and clinical observations identify obesity as an important risk factor for asthma exacerbation, but the underlying mechanisms remain poorly understood. Type 2 innate lymphoid cells (ILC2s) and type...